Silencing of the MYCN gene by siRNA delivered by folate receptor-targeted liposomes in LA-N-5 cells

Pediatric Surgery International

Volumn 26, Issue 12, 2010, Pages 1185-1191

  Feng, Chen ^a   Wang, Tianyou ^a,b   Tang, Ruihong ^a,b   Wang, Jianwen ^a   Long, Hui ^a   Gao, Xiaoning ^a   Tang, Suoqin ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CAPITAL INSTITUTE OF PEDIATRICS   (China)

Author keywords

Folate receptor; Liposome; MYCN gene; Neuroblastoma; Target therapy

Indexed keywords

CELL PROTEIN; FLUORESCENT DYE; FOLATE RECEPTOR; FOLIC ACID; LIPOSOME; MESSENGER RNA; PROTEIN MYCN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MYCN PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TISSUE; CELL GROWTH; CELL LYSATE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG TARGETING; EXPERIMENTAL NEOPLASM; FEMALE; FLUORESCENCE; GENE SILENCING; GENETIC TRANSFECTION; IN VIVO STUDY; LIPOSOMAL GENE DELIVERY SYSTEM; MICROENCAPSULATION; MICROPHOTOGRAPHY; MOUSE; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; GENETICS; HUMAN; MOLECULARLY TARGETED THERAPY; MOUSE MUTANT; TARGETED GENE REPAIR; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; FEMALE; FOLATE RECEPTORS, GPI-ANCHORED; GENE SILENCING; HUMANS; LIPOSOMES; MICE; MICE, SCID; MOLECULAR TARGETED THERAPY; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; RNA, SMALL INTERFERING; TARGETED GENE REPAIR; TRANSFECTION;

EID: 79952558724     PISSN: 01790358     EISSN: 14379813     Source Type: Journal    
DOI: 10.1007/s00383-010-2703-5     Document Type: Article

References (26)

1. Schor NF (1999) Neuroblastoma as a neurobiological disease. J Neurooncol 41:159-166 (Pubitemid 29161011)
2. Westermann F, Schwab M (2002) Genetic parameters of neuroblastomas. Cancer Lett 184:127-147 (Pubitemid 34804499)
3. Mukherjee B, Morgenbesser SD, DePinho RA (1992) Myc family oncoproteins function through a common pathway to transform normal cells in culture: Cross-interference by Max and transacting dominant mutants. Genes Dev 6:1480-1492
4. Schwab M, Alitalo K, Klempnauer KH et al (1983) Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305:245-248 (Pubitemid 14227614)
5. Brodeur GM (2003) Neuroblastoma: Biological insights into a clinical enigma. Nat Rev Cancer 3:203-216 (Pubitemid 37328872)
6. Bown N (2001) Neuroblastoma tumour genetics: Clinical and biological aspects. J Clin Pathol 54:897-910 (Pubitemid 34032883)
7. Fire A, Xu S, Montgomery MK et al (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806-811 (Pubitemid 28099681)
8. Tijsterman M, Plasterk RH (2004) Dicers at RISC: The mechanism of RNAi. Cell 117:1-3 (Pubitemid 38469891)
9. Kumar P, Ban HS, Kim SS et al (2008) T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 134:577-586
10. Sioud M (2004) Therapeutic siRNAs. Trends Pharmacol Sci 25:22-28 (Pubitemid 38076953)
11. Leamon CP, Low PS (1991) Delivery of macromolecules into living cells: A method that exploits folate receptor endocytosis. Proc Natl Acad Sci USA 88:5572-5576 (Pubitemid 21914787)
12. Zhou W, Yuan X, Wilson A et al (2002) Efficient intracellular delivery of oligonucleotides formulated in folate receptor-targeted lipid vesicles. Bioconjug Chem 13:1220-1225 (Pubitemid 35420013)
13. Lee RJ, Low PS (1994) Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J Biol Chem 269:3198-3204 (Pubitemid 24237629)
14. Rui Y, Wang S, Low PS et al (1996) Diplasmenylcholine-folate liposomes: An efficient vehicle for intracellular drug delivery. J Am Chem Soc 120:11213-11218
15. Gabizon A, Horowitz AT, Goren D et al (1999) Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)- grafted liposomes: In vitro studies. Bioconjug Chem 10:289-298 (Pubitemid 29147733)
16. Leamon CP, Weigl D, Hendren RW (1999) Folate copolymermediated transfection of cultured cells. Bioconjug Chem 10:947-957
17. Reddy JA, Dean D, Kennedy MD et al (1999) Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy. J Pharm Sci 88:1112-1118 (Pubitemid 29526294)
18. Reddy JA, Low PS (2000) Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. J Control Release 64:27-37 (Pubitemid 30035305)
19. Biewenga JE, Destree OH, Schrama LH (1997) Plasmid-mediated gene transfer in neurons using the biolistics technique. J Neurosci Methods 71:67-75 (Pubitemid 27145773)
20. Pan XQ, Zheng X, Shi G et al (2002) Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid. Blood 100:594-602 (Pubitemid 34761124)
21. Galderisi U, Di Bernardo G, Cipollaro M et al (1999) Differentiation and apoptosis of neuroblastoma cells: Role of N-myc gene product. J Cell Biochem 73:97-105 (Pubitemid 29115483)
22. Nara K, Kusafuka T, Yoneda A et al (2007) Silencing of MYCN by RNA interference induces growth inhibition, apoptotic activity and cell differentiation in a neuroblastoma cell line with MYCN amplification. Int J Oncol 30:1189-1196
23. Kim YH, Girard L, Giacomini CP et al (2006) Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification. Oncogene 25:130-138 (Pubitemid 43050011)
24. Morgenstern DA, Anderson J (2006) MYCN deregulation as a potential target for novel therapies in rhabdomyosarcoma. Expert Rev Anticancer Ther 6:217-224 (Pubitemid 44192933)
25. Mairal A, Pinglier E, Gilbert E et al (2000) Detection of chromosome imbalances in retinoblastoma by parallel karyotype and CGH analyses. Genes Chromosom Cancer 28:370-379 (Pubitemid 30451789)
26. Pession A, Tonelli R (2005) The MYCN oncogene as a specific and selective drug target for peripheral and central nervous system tumors. Curr Cancer Drug Targets 5:273-283 (Pubitemid 40910560)